Durable complete response with PANVAC and Trastuzumab in metastatic triple positive breast cancer (mTPBC)

被引：0
|
作者：
Gatti-Mays, Margaret [1 ]
Mohebtash, Mahsa [2 ]
Madan, Ravi [1 ]
Strauss, Julius [1 ]
Bilusic, Marijo [1 ]
Jochems, Caroline [1 ]
Rauckhorst, Myrna [1 ]
Jones, Elizabeth [3 ]
Dahut, William [1 ]
Schlom, Jeffrey [1 ]
Gulley, James [1 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] Medstar Union Mem Hosp, Baltimore, MD USA
[3] NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P440
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Trastuzumab emtansine in HER2-positive metastatic breast cancer
    Montemurro, Filippo
    LANCET ONCOLOGY, 2017, 18 (06): : 696 - 697
  • [22] Trastuzumab Deruxtecan in HER2-positive metastatic Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (08) : 670 - 670
  • [23] Trastuzumab therapy in HER2-positive, metastatic breast cancer
    Smith, A. D.
    Guilbert, K.
    Lister, D.
    Streilein, S.
    Bourrier, V. C.
    Lozar, B.
    Navaratnam, S.
    Harding, G. A.
    Pitz, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] HER-2-positive metastatic breast cancer: trastuzumab and beyond
    Metro, Giulio
    Mottolese, Marcella
    Fabi, Alessandra
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (15) : 2583 - 2601
  • [25] Durable response to fulvestrant therapy in a hormone receptor-positive metastatic breast cancer patient with massive metastatic disease
    Czartoryska-Arlukowicz, Bogumila
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 (06): : 344 - 346
  • [26] Real-word incidence and management of durable complete response in de novo metastatic HER2-positive breast cancer.
    Smith, Claire Elizabeth Powers
    Marcom, Paul Kelly
    Mitri, Zahi Ibrahim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Long-Term Complete Response of an Androgen Receptor-Positive Triple-Negative Metastatic Breast Cancer to Abiraterone Acetate
    Grellety, Thomas
    MacGrogan, Gaetan
    Chakiba, Camille
    Kind, Michele
    Bonnefoi, Herve
    JCO PRECISION ONCOLOGY, 2018, 2
  • [28] Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer A case report
    Barchiesi, Giacomo
    Krasniqi, Eriseld
    Barba, Maddalena
    Della Giulia, Marina
    Pizzuti, Laura
    Massimiani, Gioia
    Ciliberto, Gennaro
    Vici, Patrizia
    MEDICINE, 2019, 98 (37)
  • [29] Adjuvant Trastuzumab Benefit in Patients Diagnosed With Triple-Positive Breast Cancer
    Schott, Anne F.
    JAMA ONCOLOGY, 2016, 2 (08) : 1047 - 1048
  • [30] Trastuzumab in metastatic breast cancer after complete remission: How long is enough?
    Arzu Oguz
    Samed Rahatli
    Ozden Altundag
    Kadri Altundag
    Medical Oncology, 2015, 32
12345